Exact Mass: 399.0793

Exact Mass Matches: 399.0793

Found 24 metabolites which its exact mass value is equals to given mass value 399.0793, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Vitisidin A

7-carboxy-4,11-dihydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2λ⁴,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),2,4,6,9,11-hexaen-2-ylium

C20H15O9 (399.0716)


Vitisidin A is a polyphenol compound found in foods of plant origin (PMID: 20428313). A polyphenol compound found in foods of plant origin (PhenolExplorer)

   

Pantoprazole Sulfone

6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulphonyl]-1H-1,3-benzodiazole

C16H15F2N3O5S (399.07)


   

gamma-Glutamyldjenkol-saeuresulphoxid

gamma-Glutamyldjenkol-saeuresulphoxid

C12H21N3O8S2 (399.077)


   
   

1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-

1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-

C16H15F2N3O5S (399.07)


   

Vitisidin A

7-carboxy-4,11-dihydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2$l^{4},8-dioxatricyclo[7.3.1.0^{5,13}]trideca-1(13),2,4,6,9,11-hexaen-2-ylium

C20H15O9 (399.0716)


   

Rufloxacin hydrochloride

Rufloxacin (hydrochloride)

C17H19ClFN3O3S (399.082)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones D004791 - Enzyme Inhibitors

   

Methyl 2-(4-(2-(trifluoromethyl)benzoyl)piperazin-1-yl)thiazole-5-carboxylate

Methyl 2-(4-(2-(trifluoromethyl)benzoyl)piperazin-1-yl)thiazole-5-carboxylate

C17H16F3N3O3S (399.0864)


   

naphthol as-lc acetate

naphthol as-lc acetate

C21H18ClNO5 (399.0873)


   

2,6-difluoro-N-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-3-yl)benzamide

2,6-difluoro-N-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-3-yl)benzamide

C18H11F6N3O (399.0806)


   

Oxaliplatine

Oxaliplatine

C8H16N2O4Pt+2 (399.0758)


D000970 - Antineoplastic Agents

   

(4-Bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone

(4-Bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone

C21H22BrNO2 (399.0834)


   

(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+)

(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+)

C8H16N2O4Pt+2 (399.0758)


D000970 - Antineoplastic Agents

   

2-[(2S,3S)-2,4,6,8-tetrahydroxy-5,10-dioxo-5,10-dihydroanthra[2,3-b]furan-3-yl]ethyl acetate

2-[(2S,3S)-2,4,6,8-tetrahydroxy-5,10-dioxo-5,10-dihydroanthra[2,3-b]furan-3-yl]ethyl acetate

C20H15O9- (399.0716)


   
   

3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamide

3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamide

C22H19Cl2NO2 (399.0793)


   

N-(6-ethoxy-1,3-benzothiazol-2-yl)-2-[(3-methyl-2-imidazo[4,5-b]pyridinyl)thio]acetamide

N-(6-ethoxy-1,3-benzothiazol-2-yl)-2-[(3-methyl-2-imidazo[4,5-b]pyridinyl)thio]acetamide

C18H17N5O2S2 (399.0824)


   

(2S,3S)-versiconal hemiacetal acetate(1-)

(2S,3S)-versiconal hemiacetal acetate(1-)

C20H15O9- (399.0716)


A phenolate anion obtained by deprotonation of the 8-hydroxy group of (2S-3S)-versiconal hemiacetal acetate. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

2-Acetyl-3,4a,8,10,11,12a-hexahydroxy-1,4,4a,5,12,12a-hexahydrotetracene-1,12-dione

2-Acetyl-3,4a,8,10,11,12a-hexahydroxy-1,4,4a,5,12,12a-hexahydrotetracene-1,12-dione

C20H15O9- (399.0716)


   

N-[(E)-(2-bromo-5-methoxyphenyl)methylideneamino]-N-hydroxyoctanediamide

N-[(E)-(2-bromo-5-methoxyphenyl)methylideneamino]-N-hydroxyoctanediamide

C16H22BrN3O4 (399.0794)


   

Pantoprazole Sulfone

Pantoprazole Sulfone

C16H15F2N3O5S (399.07)


   

3-{[3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-1-sulfanylpropylidene]amino}propanoic acid

3-{[3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-1-sulfanylpropylidene]amino}propanoic acid

C16H21N3O3S3 (399.0745)


   

(2s)-2-amino-4-{[(1r)-2-({[(r)-(2r)-2-amino-2-carboxyethanesulfinyl]methyl}sulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-2-({[(r)-(2r)-2-amino-2-carboxyethanesulfinyl]methyl}sulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid

C12H21N3O8S2 (399.077)


   

2-amino-4-[(2-{[(2-amino-2-carboxyethanesulfinyl)methyl]sulfanyl}-1-carboxyethyl)-c-hydroxycarbonimidoyl]butanoic acid

2-amino-4-[(2-{[(2-amino-2-carboxyethanesulfinyl)methyl]sulfanyl}-1-carboxyethyl)-c-hydroxycarbonimidoyl]butanoic acid

C12H21N3O8S2 (399.077)